 |
| Quantity: | |
|---|---|
Description
Neutrophil gelatinase associated lipocalin (NGAL) is an early and sensitive marker of acute kidney injury. In addition, NGAL levels in blood and urine can also indicate the severity of kidney injury.
Clinical significance
✔ Early diagnosis and prevention of acute kidney injury (AKI)
✔ Risk stratification and prognosis assessment of acute renal injury (AKI)
✔ Early diagnosis of contrast mediumassociated nephropathy (CIN)
✔ Prognostic evaluation of renal injury after renal transplantation
✔ Diagnosis and prognosis of cardiorenal syndrome
✔ Early diagnosis of diabetic nephropathy
✔ Long-term monitoring of severe ICU patients
Reagent performance
Sample type | Serum/plasma/urine |
Linear range | 25.0-5000.0 ng/mL |
Precision within batch | ≤ 4% |
Precision between batch | ≤ 7% |
Reference range | ≤ 100.00ng/mL in urine ≤ 180.00ng/mL in blood |
Application department
Laboratory Department, ICU, Surgery Department, Intervention Department, Nephrology Department, Vasculocardiology Deparment, Emergency Oncology Department, Pediatric Department, Endocrinology Department, Urology Department, etc.
Product specification
Packing specification | Bottle number x capacity |
30 mL | R1:1x24 mL+R2:1x6 mL |
60 mL | R1:1x48 mL+R2:1x12 mL |
150 mL | R1:2x60 mL+R2:1x30 mL |
300 mL | R1:3x80 mL+R2:1x60 mL |
Supporting instruments
Hitachi, Abbott, Beckman, Dirui, AU400 and other Automatic Biochemical Analyzer
Description
Neutrophil gelatinase associated lipocalin (NGAL) is an early and sensitive marker of acute kidney injury. In addition, NGAL levels in blood and urine can also indicate the severity of kidney injury.
Clinical significance
✔ Early diagnosis and prevention of acute kidney injury (AKI)
✔ Risk stratification and prognosis assessment of acute renal injury (AKI)
✔ Early diagnosis of contrast mediumassociated nephropathy (CIN)
✔ Prognostic evaluation of renal injury after renal transplantation
✔ Diagnosis and prognosis of cardiorenal syndrome
✔ Early diagnosis of diabetic nephropathy
✔ Long-term monitoring of severe ICU patients
Reagent performance
Sample type | Serum/plasma/urine |
Linear range | 25.0-5000.0 ng/mL |
Precision within batch | ≤ 4% |
Precision between batch | ≤ 7% |
Reference range | ≤ 100.00ng/mL in urine ≤ 180.00ng/mL in blood |
Application department
Laboratory Department, ICU, Surgery Department, Intervention Department, Nephrology Department, Vasculocardiology Deparment, Emergency Oncology Department, Pediatric Department, Endocrinology Department, Urology Department, etc.
Product specification
Packing specification | Bottle number x capacity |
30 mL | R1:1x24 mL+R2:1x6 mL |
60 mL | R1:1x48 mL+R2:1x12 mL |
150 mL | R1:2x60 mL+R2:1x30 mL |
300 mL | R1:3x80 mL+R2:1x60 mL |
Supporting instruments
Hitachi, Abbott, Beckman, Dirui, AU400 and other Automatic Biochemical Analyzer
English
简体中文